Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 25, 2011 02:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics and Aurum Biosciences Sign Letter of Intent to Explore the Use of Oxycyte(R) PFC for Imaging and Therapeutic Intervention of Acute Ischemic Stroke

MORRISVILLE, N.C., July 25, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) and privately held Aurum Biosciences, Ltd. of Glasgow, Scotland, today...
July 20, 2011 08:00 ET | Source: Tenax Therapeutics, Inc.

Global Interest in the Potential Medical Benefits of Novel Perfluorocarbon At All Time High

MORRISVILLE, N.C., July 20, 2011 (GLOBE NEWSWIRE) -- University and educational institution researchers from the United Kingdom, Switzerland and the United States all have one thing in common: an...
July 14, 2011 18:02 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Reports Financial Results for Fiscal Year 2011

MORRISVILLE, N.C., July 14, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
July 01, 2011 16:05 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Announces Closing of Its Previously Announced Private Placement of Unregistered Convertible Notes and Warrants

MORRISVILLE, N.C., July 1, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that it closed its previously announced private placement of...
June 22, 2011 12:10 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Announces $4.6 Million Private Placement of Unregistered Convertible Note and Warrants

MORRISVILLE, N.C., June 22, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that it has entered into an agreement for the issuance and...
June 07, 2011 02:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Receives Approval to Expand Phase IIb Trials With Oxycyte(R) PFC for Traumatic Brain Injury Into India

MORRISVILLE, N.C., June 7, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has received approval by the Drug Controller General of...
March 31, 2011 17:30 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics' Chairman and CEO Chris Stern Announces Retirement of President and COO Richard Kiral

MORRISVILLE, N.C., March 31, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced the Board of Directors accepted the resignation of President...
March 21, 2011 18:03 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Reports Financial Results for Third Quarter FY2011

MORRISVILLE, N.C., March 21, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
March 14, 2011 18:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Announces Third Quarter FY2011 Financial Results Conference Call and Webcast

MORRISVILLE, N.C., March 14, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that the Company plans to report third quarter fiscal year...
March 10, 2011 02:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Signs Agreement to Sell DERMACYTE Products to Mexican Sales and Distribution Company

MORRISVILLE, N.C., March 10, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has entered into an agreement with independently owned and...